STRYKER CORPORATION (NYSE:SYK) Files An 8-K Entry into a Material Definitive AgreementItem 1.01
| 4.2 | Fifteenth Supplemental Indenture (including the form of the note), dated November30, 2018, between Stryker Corporation and U.S. Bank National Association, as trustee. |
| 4.3 | Sixteenth Supplemental Indenture (including the form of the note), dated November30, 2018, between Stryker Corporation and U.S. Bank National Association, as trustee. |
| 4.4 | Seventeenth Supplemental Indenture (including the form of the note), dated November30, 2018, between Stryker Corporation and U.S. Bank National Association, as trustee. |
| 4.5 | Eighteenth Supplemental Indenture (including the form of the note), dated November30, 2018, between Stryker Corporation and U.S. Bank National Association, as trustee. |
| 5.1 | Opinion Letter of Skadden, Arps, Slate, Meagher& Flom LLP regarding the validity of the Notes. |
| 5.2 | Opinion Letter of Warner Norcross& Judd LLP regarding the validity of the Notes. |
| 23.1 | Consent of Skadden, Arps, Slate, Meagher& Flom LLP (included as part of Exhibit 5.1). |
| 23.2 | Consent of Warner Norcross& Judd LLP (included as part of Exhibit 5.2). |
STRYKER CORP ExhibitEX-1.1 2 d661644dex11.htm EX-1.1 EX-1.1 Exhibit 1.1 STRYKER CORPORATION €300,…To view the full exhibit click here
About STRYKER CORPORATION (NYSE:SYK)
Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties. The Company’s Neurotechnology and Spine segment products consist of both neurosurgical and neurovascular devices. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors.
